文献速递心脑血管急症呼吸衰竭与机械通气

慢性阻塞性肺疾病急性加重后非致死性心血管事件的时间风险:一项基于人群的研究

Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based Study.
PubMed 文献 · Am J Respir Crit Care Med · 2024-01-01
一句话结论COPD急性加重后14天内非致死性心血管事件风险显著升高,重度加重后1-14天aHR达14.5,风险持续超过1年。

该研究基于英国临床实践研究数据链Aurum初级保健数据库,纳入2014至2020年213,466例COPD患者,分析中度和重度急性加重与需住院的非致死性心血管事件(急性冠脉综合征、心律失常、心力衰竭、缺血性卒中、肺动脉高压)的时间关系。结果显示,任何急性加重后1-14天心血管事件风险立即升高(aHR 3.19,95%CI 2.71-3.76),此后逐渐下降但持续存在,1年后仍升高(aHR 1.84,95%CI 1.78-1.91)。重度加重后1-14天风险最高(aHR 14.5,95%CI 12.2-17.3),而中度加重后14-30天风险最高(aHR 1.94,95%CI 1.63-2.31)。作者认为,急性加重后立即期是临床干预和治疗优化以预防未来心血管事件的关键机会。

要点

  • 任何COPD急性加重后1-14天,非致死性住院心血管事件风险立即升高(aHR 3.19,95%CI 2.71-3.76)。
  • 重度急性加重后1-14天心血管事件风险最高(aHR 14.5,95%CI 12.2-17.3),其中心律失常(aHR 12.7,95%CI 10.3-15.7)和心力衰竭(aHR 8.31,95%CI 6.79-10.2)风险最高。
  • 中度急性加重后14-30天心血管事件风险最高(aHR 1.94,95%CI 1.63-2.31),出现略晚于重度加重。
  • 无论加重严重程度,心血管事件相对风险在1年后仍升高(aHR 1.84,95%CI 1.78-1.91)。
  • 作者认为,急性加重后立即期是临床干预和治疗优化以预防未来心血管事件的关键机会。

适用人群与场景

  • 2014至2020年英国初级保健来源的COPD患者,纳入临床实践研究数据链Aurum数据库。
  • 索引日期为首次COPD急性加重日期,无急性加重者为符合条件日期。

研究设计与关键结果

  • 研究类型:基于人群的队列研究,纳入213,466例COPD患者,其中146,448例(68.6%)有急性加重,119,124例(55.8%)为中度加重,27,324例(12.8%)为重度加重;共记录40,773例心血管事件。
  • 任何急性加重后1-14天心血管事件aHR为3.19(95%CI 2.71-3.76),1年后aHR为1.84(95%CI 1.78-1.91)。
  • 重度急性加重后1-14天aHR最高,为14.5(95%CI 12.2-17.3);中度急性加重后14-30天aHR最高,为1.94(95%CI 1.63-2.31)。
  • 重度急性加重后两周效应最大的心血管结局为心律失常(aHR 12.7,95%CI 10.3-15.7)和心力衰竭(aHR 8.31,95%CI 6.79-10.2)。

证据类型、等级与局限

  • 证据类型:基于初级保健数据库的队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,急性加重后立即期是临床干预和治疗优化以预防未来心血管事件的关键机会。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Rationale: Cardiovascular events after chronic obstructive pulmonary disease (COPD) exacerbations are recognized. Studies to date have been post hoc analyses of trials, did not differentiate exacerbation severity, included death in the cardiovascular outcome, or had insufficient power to explore individual outcomes temporally.Objectives: We explore temporal relationships between moderate and severe exacerbations and incident, nonfatal hospitalized cardiovascular events in a primary care-derived COPD cohort.Methods: We included people with COPD in England from 2014 to 2020, from the Clinical Practice Research Datalink Aurum primary care database. The index date was the date of first COPD exacerbation or, for those without exacerbations, date upon eligibility. We determined composite and individual cardiovascular events (acute coronary syndrome, arrhythmia, heart failure, ischemic stroke, and pulmonary hypertension) from linked hospital data. Adjusted Cox regression models were used to estimate average and time-stratified adjusted hazard ratios (aHRs).Measurements and Main Results: Among 213,466 patients, 146,448 (68.6%) had any exacerbation; 119,124 (55.8%) had moderate exacerbations, and 27,324 (12.8%) had severe exacerbations. A total of 40,773 cardiovascular events were recorded. There was an immediate period of cardiovascular relative rate after any exacerbation (1-14 d; aHR, 3.19 [95% confidence interval (CI), 2.71-3.76]), followed by progressively declining yet maintained effects, elevated after one year (aHR, 1.84 [95% CI, 1.78-1.91]). Hazard ratios were highest 1-14 days after severe exacerbations (aHR, 14.5 [95% CI, 12.2-17.3]) but highest 14-30 days after moderate exacerbations (aHR, 1.94 [95% CI, 1.63-2.31]). Cardiovascular outcomes with the greatest two-week effects after a severe exacerbation were arrhythmia (aHR, 12.7 [95% CI, 10.3-15.7]) and heart failure (aHR, 8.31 [95% CI, 6.79-10.2]).Conclusions: Cardiovascular events after moderate COPD exacerbations occur slightly later than after severe exacerbations; heightened relative rates remain beyond one year irrespective of severity. The period immediately after an exacerbation presents a critical opportunity for clinical intervention and treatment optimization to prevent future cardiovascular events.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Graul EL, Nordon C, Rhodes K, et al. Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based Study. Am J Respir Crit Care Med. 2024. PMID: 38127850. doi:10.1164/rccm.202307-1122OC

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。